Breaking News Instant updates and real-time market news.

2016-11-23 12:40:03

GFI

Gold Fields

$3.07

-0.06 (-1.92%)

12:40

11/23/16

11/23

12:40

11/23/16

12:40

Flurry of activity in Gold Fields Jan 3 calls Wednesday morning

Flurry of activity in Gold Fields Jan 3 calls Wednesday morning. Multi-exchange sweeps traded for 27 up to 33c per contract and data from ISE is reporting opening buying for customer accounts. Shares are down 8c to $3.05 amid broader weakness in the mining sector and nearly 50K traded at that strike, making it the third most active option of the day behind SPDR Financial (XLF) Mar 23 and 24 calls.

GFIGold Fields

$3.07

-0.06 (-1.92%)

09/02/16

MACQ

09/02/16UPGRADEMACQOutperform

Gold Fields upgraded to Outperform from Neutral at Macquarie (earlier)

Macquarie analyst Yatish Chowthee upgraded earlier today Gold Fields to Outperform following meetings with management and the company's first half of 2016 results. The analyst believes Gold Fields' turnaround at South Deep is gaining momentum. Chowthee has a R90 price target, which represents around 23% upside.

07/12/16

JPMS

07/12/16UPGRADETarget $5.61JPMSNeutral

Gold Fields upgraded to Neutral from Underweight at JPMorgan

JPMorgan analyst Allan Cooke upgraded Gold Fields to Neutral citing the stock's underperformance this year. The analyst raised his price target for the shares to $5.61 from $4.

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chesapeake Utilities (CPK) initiated with a Neutral at Ladenburg. 2. CONSOL (CNX) initiated with a Neutral at Goldman. 3. Johnson Controls (JCI) assumed with an Equal Weight at Barclays. 4. American Midstream Partners (AMID) initiated with a Buy at Janney Capital. 5. Brookfield Infrastructure (BIP) coverage resumed with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Abercrombie & Fitch (ANF) downgraded to Sell from Hold at Argus with analysts John Eade and Katelyn Bayone citing the company's third quarter miss and what they see as its "challenging sales outlook for the remainder of the year." 2. Duluth Holdings (DLTH) downgraded to Hold from Buy at Stifel and to Market Perform from Outperform at William Blair. 3. DAVIDsTEA (DTEA) downgraded to Market Perform from Outperform at BMO Capital and to Market Perform from Outperform at William Blair. 4. Hilton (HLT) downgraded to Outperform from Buy at CLSA with analyst Jon Oh citing valuation. 5. Horizon Pharma (HZNP) downgraded to Neutral from Buy at Mizuho. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) upgraded to Outperform from Market Perform at Leerink with analyst Seamus Fernandez saying the recent weakness in shares provides an "excellent entry point" ahead of several critical pipeline events that have the potential "to transform this giant into an exciting growth story." 2. Autodesk (ADSK) upgraded to Buy from Hold at Canaccord with analyst Richard Davis citing expectations for improved free cash flow, as he sees a path to $6 in FCF by 2020 and $11 per share in 2022. 3. Eaton (ENT) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying optionality of the company's balance sheet should offset broad weakness across its end markets. 4. Fluor (FLR) upgraded to Buy from Neutral at Citi with analyst Andrew Kaplowitz saying the company is positioned to outperform given amid oil and gas capex stabilization, a lift off the bottom in mining off the bottom and "muted" 2017 expectations. 5. Sysco (SYY) upgraded to Neutral from Sell at Goldman. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.